Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.605 USD | +18.63% | +37.50% | -95.99% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 529K |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | - |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 week | +37.50% | ||
Current month | -13.57% | ||
1 month | +78.47% | ||
3 months | -95.91% | ||
6 months | -93.73% | ||
Current year | -95.99% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.605 | +18.63% | 5,839 |
24-05-16 | 0.51 | -20.31% | 538 |
24-05-15 | 0.64 | +68.42% | 31,214 |
24-05-14 | 0.38 | +5.53% | 26,520 |
24-05-13 | 0.3601 | -18.16% | 41,756 |
Delayed Quote Nasdaq, May 17, 2024 at 03:49 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock